Mochida Pharmaceutical Co., Ltd.
Mochida Pharmaceutical Co., Ltd. has 1 licensing announcement in this dataset, dated 2018-06-12.
- Country / operating region
- Japan
- Ticker
- 查無
- Headquarters
- 查無
- Founded
- 1913
- Business
- Biopharmaceutical research and development
- Website
- www.mochida.co.jp
Pipeline / products
| Asset / platform | Target | Modality | Stage at announcement | Announcement date |
|---|---|---|---|---|
| EPA-based drug products and indications | 查無 | 查無 | 查無 | 2018-06-12 |
| Asset | Registered / announced phase | Trial | Status | Sponsor | Record date |
|---|---|---|---|---|---|
| MD-352 (dienogest formulation) | Phase II/III (2026-08-03 pipeline) | — | 查無 | 查無 | 2026-08-03 |
Licensing deals
| Date | Counterparty | Asset / platform | Upfront | Near-term | Milestones | Potential total | Other disclosed terms |
|---|---|---|---|---|---|---|---|
| 2018-06-12 | Amarin Corporation plc | EPA-based drug products and indications | USD 2.7m | 查無 | 查無 | 查無 | — |
| Counterparty | Territory | Royalties |
|---|---|---|
| Amarin Corporation plc | United States and certain other territories | Milestone payments and royalties on net sales of future products; amounts and rates not disclosed. |
Catalysts
查無
Latest monthly revenue
查無
Most advanced drug
查無
Drugnews analysis
查無